Scalper1 News
Stock in Sanofi fell Tuesday after the French drugmaker warned that sales of its diabetes products face a more challenging environment due to mounting competition in the U.S. The warning comes amid tension at the top of the company. On Monday, Sanofi (SNY) CEO Chris Viehbacher asked for, but did not receive, confirmation of the support of Chairman Serge Weinberg and the board, Reuters reported. According to the report, directors say that Scalper1 News
Scalper1 News